Problem

Many treatments and drugs fail to shrink tumors that have metastasized.

The Gift

Your gift will enable Memorial Sloan-Kettering Cancer Center to continue to be on the forefront of research into new colorectal chemotherapy drugs. Memorial Sloan-Kettering helped establish the efficacy of irinotecan, the first new drug for colorectal cancer in 40 years. In some patients, irinotecan has been found to shrink metastatic tumors when other treatments have failed.